This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: EXPE, WAG, UAL, RE

Stocks in this article: EAT EXPE MJN RE SLXP UAL WAG

NEW YORK ( TheStreet) --

STOCK COMMENTS / EPS CHANGES

Baxter International (BAX) is upgraded to buy at TheStreet Ratings.

Brinker (EAT - Get Report) numbers raised at UBS. Shares of EAT now seen reaching $30. Estimates also increased on positive SSS. Buy rating.

Expedia (EXPE - Get Report) numbers raised at UBS. Shares of EXPE now seen reaching $33. Estimates also increased after TipAdvisor spin off. Neutral rating.

Mead Johnson Nutrition (MJN - Get Report) numbers lowered at Goldman Sachs. Shares of MJN now seen reaching $74. Estimates also lowered on product safety fears. Neutral rating.

Everest Re (RE - Get Report) numbers lowered at UBS. Shares of RE now seen reaching $105. Estimates also lowered on Thailand floods. Buy rating.

Salix Pharmaceuticals numbers raised at Goldman Sachs. Shares of SLXP now seen reaching $46. Estimates also raised on positive Phase III data. Neutral rating.

United Continental (UAL - Get Report) estimates lowered at UBS through 2012. Company guides down. Buy rating and $35 price target.

Walgreen (WAG) numbers lowered at Jefferies. Shares of WAG now seen reaching $34. Estimates also lowered on ongoing uncertainty surrounding the ESRX contract. Hold rating.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:






Follow TheStreet on Twitter and become a fan on Facebook.



This article was written by a staff member of RealMoney.com.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,325.82 -91.03 -0.52%
S&P 500 2,015.81 -5.44 -0.27%
NASDAQ 4,690.7210 +7.3140 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs